Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies-Reference-Cited by-同舟云学术

Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies

Published:2018-05-18 Issue:3 Volume:74 Page:169-179
ISSN:1784-3286
Container-title:Acta Clinica Belgica
language:en
Short-container-title:Acta Clinica Belgica

Author:

Bastin Julie¹^ORCID,Werbrouck Emilie¹^ORCID,Verbiest Annelies¹,Punie Kevin¹,Bechter Oliver¹,Woei-A-Jin Feng Jung¹,Wolter Pascal²,Wildiers Hans¹,Lerut Evelyne³,Dumez Herlinde¹,Decallonne Brigitte⁴,Clement Paul¹,Vanderschueren Dirk⁴,Albersen Maarten⁵,Oyen Raymond⁶,Schöffski Patrick¹,Beuselinck Benoit¹

Affiliation:

1. Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, KULeuven, Leuven, Belgium

2. Department of General Medical Oncology, St. Nikolaus-Hospital Eupen, Eupen, Belgium

3. Department of Pathology, University Hospitals Leuven, KULeuven, Leuven, Belgium

4. Department of Endocrinology, University Hospitals Leuven, KULeuven, Leuven, Belgium

5. Department of Urology, University Hospitals Leuven, KULeuven, Leuven, Belgium

6. Department of Radiology, University Hospitals Leuven, KULeuven, Leuven, Belgium

Funder

Pfizer

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17843286.2018.1476115

Reference20 articles.

1. Testosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to Androgens

2. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

3. Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

4. Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Drugs-Related Hypogonadism in Male Patients with Advanced Cancers on Active Treatment: A Systematic Review;The Oncologist;2024-03-22

2. Endocrine-related adverse conditions induced by tyrosine kinase inhibitors;Annales d'Endocrinologie;2023-05

3. Fertility preservation and PGT-M in women with familial adenomatous polyposis-associated desmoid tumours;Reproductive BioMedicine Online;2021-10

4. Testosterone for Managing Treatment-related Fatigue in Patients With Metastatic Renal Cell Carcinoma;American Journal of Clinical Oncology;2021-01-27

5. An Unusual Case of Hypopituitarism as an Adverse Effect of Vandetanib and Remission of Breast Metastases in a Patient with Medullary Thyroid Cancer;Oncology Research and Treatment;2021